Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of PHIO will decline by -14.42% over the next 2 Weeks and hit $0.77 by Monday, February 23, 2026. In that time frame, PHIO's share price is expected to range between $0.73 and $0.82.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Feb 23, 2026 | 0.73 | 0.77 | 0.82 |
| Feb 20, 2026 | 0.75 | 0.79 | 0.84 |
| Feb 19, 2026 | 0.75 | 0.79 | 0.83 |
| Feb 18, 2026 | 0.75 | 0.79 | 0.83 |
| Feb 17, 2026 | 0.76 | 0.80 | 0.84 |
| Feb 16, 2026 | 0.79 | 0.83 | 0.88 |
| Feb 13, 2026 | 0.82 | 0.86 | 0.90 |
| Feb 12, 2026 | 0.81 | 0.85 | 0.89 |
| Feb 11, 2026 | 0.81 | 0.86 | 0.90 |
| Feb 10, 2026 | 0.83 | 0.87 | 0.91 |
PHIO shares rose +24.44% in Tuesday, February 10, 2026's trading session, rising from a previous close of $0.90 to move at $1.12. The stock demonstrated notable intraday movement (see PHIO's key stats for a full breakdown), fluctuating between $1.12 and $1.48, a +32.14% trading range. While recent weeks have seen some volatility, PHIO has managed to secure a +9.80% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 161.29M shares changing hands, 161.19M more than the previous session. This amounted to $180.64M in total market activity.
Will PHIO Continue Its Downward Trend?
According to analyst ratings and projections for PHIO, Phio Pharmaceuticals Corp. shares are anticipated to decrease by -37.11%, potentially reaching $0.82 per share by February 23, 2026. Short-term technical indicators currently suggest a neutral sentiment for PHIO. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the PHIO stock forecast, now is not the best time to buy PHIO stock because its current trading price is +45.42% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on PHIO covering social and institutional perspectives.
PHIO Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into PHIO's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 51.20% to 62.80%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 44.31%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 45.19%, maintains a neutral outlook for the long term. Insights into PHIO's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Phio Pharmaceuticals Short-Term Forecasts
PHIO Forecast For Next 5 Days
Our algorithm anticipates Phio Pharmaceuticals (PHIO) stock could hit $0.84 by Feb 17, 2026. This represents a -24.75% fall from today's price, following a -9.24% change over the past five days.
PHIO Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Phio Pharmaceuticals Corp. (PHIO) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.85, which would mean a -24.11% decrease from the current price of $1.12. Projections for this period range from a high of $1.10 to a low of $0.71.
PHIO Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Phio Pharmaceuticals's price over the next three months point to a rise. PHIO stock is expected to peak at $2.69 on Mar 03, 2026 before potentially dipping to $0.65 on Apr 17, 2026. On average, PHIO is likely to trade around $1.69 in the coming 90 days.
Phio Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Phio Pharmaceuticals (PHIO) is expected to trade between $0.21 and $3.22 throughout 2026. This would result in an average price of $1.60, potentially offering investors a +42.86% return from current levels.
Phio Pharmaceuticals Corp. Monthly Forecast 2026–2027
February 2026
According to our latest forecast models, Phio Pharmaceuticals Corp. (PHIO) is positioned to show a strong performance in February 2026. The price is predicted to move between $0.69 and $2.66, settling at an average of $1.66. This could translate to a +48.21% gain.
March 2026
Based on current market signals, Phio Pharmaceuticals Corp. is projected to trend march 2026. We forecast a trading range from $1.36 to $2.69, with a likely average price of $2.00. Investors could expect a potential return of +78.57%.
April 2026
Our predictive algorithms indicate Phio Pharmaceuticals Corp. stock may see a shift in April 2026. The expected range spans $0.65–$2.43, with an average target of $1.42. This represents a positive outlook and a possible gain of +26.79%.
May 2026
Analyzing established trends, Phio Pharmaceuticals Corp. looks set to move in May 2026. Projections place the stock between $0.82 and $3.22, averaging around $2.20. This suggests a +96.43% gain from current levels.
June 2026
Market indicators suggest Phio Pharmaceuticals Corp. could experience notable changes during June 2026. Prices could fluctuate within $0.65 to $2.68, with a midpoint forecast of $1.57. The stock might deliver a +40.18% gain.
July 2026
Forecasting for July 2026, models estimate that Phio Pharmaceuticals Corp. may undergo key fluctuations. If trends hold, the stock might trade between $0.58 and $2.76, averaging $1.74. This signals a positive trajectory with potential returns around +55.36%.
August 2026
According to our latest forecast models, Phio Pharmaceuticals Corp. (PHIO) is positioned to show a strong performance in August 2026. The price is predicted to move between $0.99 and $2.69, settling at an average of $1.78. This could translate to a +58.93% gain.
September 2026
Based on current market signals, Phio Pharmaceuticals Corp. is projected to trend september 2026. We forecast a trading range from $0.48 to $2.18, with a likely average price of $1.21. Investors could expect a potential return of +8.04%.
October 2026
Our predictive algorithms indicate Phio Pharmaceuticals Corp. stock may see a shift in October 2026. The expected range spans $0.79–$2.86, with an average target of $1.87. This represents a positive outlook and a possible gain of +66.96%.
November 2026
Analyzing established trends, Phio Pharmaceuticals Corp. looks set to move in November 2026. Projections place the stock between $0.24 and $2.14, averaging around $1.09. This suggests a -2.68% loss from current levels.
December 2026
Market indicators suggest Phio Pharmaceuticals Corp. could experience notable changes during December 2026. Prices could fluctuate within $0.21 to $2.00, with a midpoint forecast of $1.11. The stock might deliver a -0.89% loss.
January 2027
Forecasting for January 2027, models estimate that Phio Pharmaceuticals Corp. may undergo key fluctuations. If trends hold, the stock might trade between $0.40 and $2.11, averaging $1.35. This signals a positive trajectory with potential returns around +20.54%.
February 2027
According to our latest forecast models, Phio Pharmaceuticals Corp. (PHIO) is positioned to show a strong performance in February 2027. The price is predicted to move between $0.00 and $1.38, settling at an average of $0.73. This could translate to a -34.82% loss.
PHIO's history of dividends and stock splits also plays a role in long-term investor confidence.

